Comparison

Human Glucosylceramidase Protein, His Tag European Partner

Item no. GLE-H52H3-100ug
Manufacturer ACROBiosystems
Amount 100 ug
Quantity options 100 ug 1 mg 20 ug
Category
Type Enzymes
Format Liquid
Specific against Human (Homo sapiens)
Host HEK293
Conjugate/Tag Unconjugated, HIS
Purity 90%
Dry ice Yes
NCBI NP_001005741.1
ECLASS 10.1 32160410
ECLASS 11.0 32160410
UNSPSC 12352204
Alias Glucosylceramidase,GBA,Acid beta-glucosidase; Alglucerase; beta-glucocerebrosidase; D-glucosyl-N-acylsphingosine glucohydrolase; EC 3.2.1.45; GBA; GBA1; GC; GCB; GLUC; glucosidase, beta, acid; glucosidase, beta; acid (includes glucosylceramidase); Glucosy
Shipping condition Dry ice
Available
Manufacturer - Category
Protein / Enzymes
Manufacturer - Conjugate / Tag
Unconjugated, C-10xHis
Shipping Temperature
Dry ice
Storage Conditions
-70°C
Molecular Weight
57.5 kDa
Description
Human Glucosylceramidase, His Tag (GLE-H52H3) is expressed from human 293 cells (HEK293). It contains AA Ala 40 - Gln 536 (Accession # P04062-1).
Background
Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, it plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, it participates in the PKC-activated salvage pathway of ceramide formation and plays a role in cholesterol metabolism. It may either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. Defects in Glucosylceramidase are the cause of Gaucher disease, also known as glucocerebrosidase deficiency. Gaucher disease is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Currently, enzyme replacement therapy is used to treat patients with the disease.
Molecule
Glucosylceramidase
Exp Region
Ala 40 - Gln 536
Characteristics
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 57.5 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
1.0 EU per μg
Buffer
PBS
Stability
● The product MUST be stored at -70°C or lower upon receipt;
● -70°C for 3 months under sterile conditions.
Protectant
Glycerol

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?